Risk Prediction and Its Intelligent Assessment for Cognitive Impairment Among Community-dwelling Older Adults
NCT ID: NCT05385874
Last Updated: 2024-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13228 participants
OBSERVATIONAL
2022-04-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Beijing Disability Risk and Ageing Monitoring Study
NCT06394817
Hainan Community Cognition Cohort
NCT06686186
Cognitive Changes in Mild Cognitive Impairment
NCT05821400
Trajectory of Frailty and Cognitive Dysfunction in Older Adults
NCT06276166
The "Motoric Cognitive Risk" Syndrome in the Canadian Population
NCT03679026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training cohort
The training cohort will be used for model development.
No interventions assigned to this group
Testing cohort
The testing cohort, a new cohort compared with the training cohort, will be used for model external validation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. With normal cognitive function at baseline (score ≥ 18 on the Chinese version of Mini-Mental State Examination, MMSE);
3. Completed MMSE assessment three years later;
4. Provided informed consent voluntarily.
Exclusion Criteria
2. had a history of dementia or MMSE score \< 18 at baseline;
3. lost to follow-up or without cognitive function assessment three years later;
4. Refused to participate the survey.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Sixth Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaozhen LV
Associate Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feifei Gao, Ph.D
Role: STUDY_DIRECTOR
Peking University Six Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Six Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHOUFA2020-3-4114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.